Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase‐induced cardiomyopathy: involvement of mitofusin‐2

BACKGROUND AND PURPOSE: The anthracycline doxorubicin (DOX), although successful as a first‐line cancer treatment, induces cardiotoxicity linked with increased production of myocardial ROS, with Nox2 NADPH oxidase‐derived superoxide reported to play a key role. The aim of this study was to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: McLaughlin, Declan, Zhao, Youyou, O'Neill, Karla M, Edgar, Kevin S, Dunne, Philip D, Kearney, Anna M, Grieve, David J, McDermott, Barbara J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Themed Section: Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647180/
https://www.ncbi.nlm.nih.gov/pubmed/28261787
http://dx.doi.org/10.1111/bph.13773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647180/
https://www.ncbi.nlm.nih.gov/pubmed/28261787
http://dx.doi.org/10.1111/bph.13773

Ejemplares similares